Preclinical toxicology of platinum analogues in dogs
- 1 August 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (8) , 1147-1154
- https://doi.org/10.1016/0277-5379(87)90148-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056)Cancer Chemotherapy and Pharmacology, 1985
- A Phase I trial of Cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleInvestigational New Drugs, 1984
- Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivativesEuropean Journal of Cancer and Clinical Oncology, 1984
- New platinum complexes in clinical trialsCancer Treatment Reviews, 1983
- PHASE-I CLINICAL-TRIAL OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM(IV) (CHIP)1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- CISPLATIN-INDUCED EMESIS IN THE FERRET - A NEW ANIMAL-MODEL1982
- Toxicology screening in small animalsCancer Treatment Reviews, 1981
- Selection of potential second generation platinum compoundsBiochimie, 1978
- Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumorsCancer, 1974